David P Sullivan

US Patent:

6738268, May 18, 2004

Filed:

Nov 28, 2001

Appl. No.:

09/995919

Inventors:

David Sullivan - Londonderry NH
Robert MacArthur - Leominster MA

Assignee:

EMC Corporation - Hopkinton MA

International Classification:

H02M 7517

US Classification:

363 49, 363 65, 323901

Abstract:

A technique involves providing a set of soft start power signals to operating circuitry mounted on a circuit board. In particular, the technique involves enabling (i) a first converter to provide a first soft start power signal to the operating circuitry and (ii) a second converter to provide a second soft start power signal to the operation circuitry. Additionally, the technique involves providing a first control signal that indicates whether the first converter properly provides the first soft start power signal, and providing a second control signal that indicates whether the second converter properly provides the second soft start power signal. Furthermore, the technique involves disabling the first converter if the second control signal indicates that the second converter improperly provides the second soft start power signal, and disabling the second converter if the first control signal indicates that the first converter improperly provides the first soft start power signal.

US Patent:

6862200, Mar 1, 2005

Filed:

Dec 16, 2003

Appl. No.:

10/737317

Inventors:

David Sullivan - Londonderry NH, US
Robert MacArthur - Leominster MA, US

Assignee:

EMC Corporation - Hopkinton MA

International Classification:

H02M003/335

US Classification:

363 65, 363 72

Abstract:

A technique involves providing a set of soft start power signals to operating circuitry mounted on a circuit board. In particular, the technique involves enabling (i) a first converter to provide a first soft start power signal to the operating circuitry and (ii) a second converter to provide a second soft start power signal to the operation circuitry. Additionally, the technique involves providing a first control signal that indicates whether the first converter properly provides the first soft start power signal, and providing a second control signal that indicates whether the second converter properly provides the second soft start power signal. Furthermore, the technique involves disabling the first converter if the second control signal indicates that the second converter improperly provides the second soft start power signal, and disabling the second converter if the first control signal indicates that the first converter improperly provides the first soft start power signal.

US Patent:

56209215, Apr 15, 1997

Filed:

Sep 21, 1993

Appl. No.:

8/124842

Inventors:

David A. Sullivan - Acton MA

Assignee:

The Schepens Eye Research Institute, Inc. - Boston MA

International Classification:

A61K 3156

US Classification:

514178

Abstract:

The topical application to the ocular surface or adjacent regions of the eye of a preparation containing a therapeutic amount of an androgen or androgen analogue is disclosed as a method of relieving the chronic and acute manifestation of dry eye symptoms in Sj ogren's syndrome.

US Patent:

43453945, Aug 24, 1982

Filed:

Jun 19, 1981

Appl. No.:

6/275353

Inventors:

David T. Sullivan - Nashua NH

International Classification:

B42F 1900

US Classification:

40405

Abstract:

An arrangement for providing a pocket sheet (10) having inserts (42) located in pockets of the pocket sheet with information placed on the inserts exposed. The arrangement involves providing an insert sheet (34) having substantially the same length and width as the pocket sheet, the insert sheet having a plurality of inserts (42) on which the information may be placed, after which the inserts may be separated from each other and placed in the pockets.

US Patent:

61050288, Aug 15, 2000

Filed:

Jun 26, 1997

Appl. No.:

8/882882

Inventors:

David J. Sullivan - Nashua NH
William Joseph Gauvin - Leominster MA
Edward James Taranto - Boston MA

Assignee:

Digital Equipment Corporation - Maynard MA

International Classification:

G06F 1730

US Classification:

707 10

Abstract:

A method and apparatus for enabling access of a document on a remote network device by a local computer includes an interceptor for intercepting a request (from a web browser on the local computer system) for accessing the document. The interceptor responsively ascertains whether the local computer is connected to a network and, if connected to the network, downloads the document into memory of the local computer system. If the local computer is not connected to the network, the method and apparatus locates the document in the local memory of the local computer. Once downloaded or located, whichever the case may be, the document may be utilized by the user, such as by displaying the document on a display device.

US Patent:

59589124, Sep 28, 1999

Filed:

Nov 17, 1997

Appl. No.:

8/971768

Inventors:

David A. Sullivan - Acton MA

Assignee:

The Schepens Eye Research Institute, Inc. - Boston MA

International Classification:

A61K 3133

US Classification:

514177

Abstract:

The topical application to the ocular surface or adjacent regions of the eye of a preparation containing a therapeutically effective amount of an androgen or androgen analogue or a therapeutically effective amount of TGB-. beta. is disclosed as a method of relieving the chronic and acute manifestation of dry eye signs and symptoms in keratoconjunctivitis sicca (KCS), for example in Sjogren's syndrome. Measurement of the increased tear levels of TGF-. beta. is disclosed as a diagnostic test to monitor the therapeutic effect of topical treatment with androgen or androgen analogues.

US Patent:

56887655, Nov 18, 1997

Filed:

Jun 7, 1995

Appl. No.:

8/477301

Inventors:

David A. Sullivan - Acton MA

Assignee:

The Schepens Eye Research Institute, Inc. - Boston MA

International Classification:

A61K 3700

US Classification:

514 12

Abstract:

The topical application to the ocular surface or adjacent regions of the eye of a preparation containing a therapeutic amount of an androgen or androgen analogue or a therapeutic amount of TGF-. beta. is disclosed as a method of relieving the chronic and acute manifestation of dry eye symptoms in Sjogren's syndrome. Measurement of the increased tear levels of TGF-. beta. is disclosed as a diagnostic test to monitor the therapeutic effect of topical treatment with androgen or androgen analogues.

US Patent:

61072893, Aug 22, 2000

Filed:

Mar 17, 1999

Appl. No.:

9/271600

Inventors:

David A. Sullivan - Acton MA

Assignee:

The Schepens Eye Research Institute, Inc. - Boston MA

International Classification:

A61K 3156

US Classification:

514178

Abstract:

The topical application, at a dose rate less than or equal to 0. 1 mg day, to the ocular surface or adjacent regions of the eye of a preparation containing a therapeutically effective amount of an androgen or androgen analogue or a therapeutically effective amount of TGF-. beta. is disclosed as a method of relieving the chronic and acute manifestation of dry eye signs and symptoms in keratoconjunctivitis sicca (KCS), for example in Sjogren's syndrome.